I have now been given more information by Leena Menghaney from MSF.
Atazanavir:
Three applications/ Patents:
US Patent: 5849911, Issue date: 1998-12-15
Application: 08/831,630, Filing date: 1997-04-09
Indian application No. 805/MAS/97
Novartis Finance Corporation
Impact: on generic production of atazanavir, could have been granted in
Current patent status in
Copy of opposition brief from Lawyer’s Collective.
Indian Patent office has now informed that the patent application was deemed abandoned in
Copy of the letter from Patent Office.
2. Bisulfate salt of HIV protease inhibitor
US Patent: 6087383, Issue date: 2000-07-11
Application: 09/217,538, Filing date: 1998-12-21
Bristol-Myers Squibb Company
Corresponding Indian Patent application not found as yet
3. Title: Process for preparing Atazanavir Bisulphate and Novel Forms
Indian application No. 6425/DELNP/2006 A
Application by BMS in
Priority Data: PCT/US2005/015333
60/568,043 | 2004-05-04 | |
60/607,533 | 2004-09-07 | |
11/119,558 | 2005-05-02 |
Patent status: not granted yet, but no opposition filed
No comments:
Post a Comment